CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses
DOI 10.1055/a-2221-3036
Bibliografische Angaben
Nachweis in CareLit
Autor:innenRakan Al-Rashdan, Haneen Al-Abdallat, Mike Machaba Sathekge, Siroos Mirzaei, Mohammed Shahait, Khaled Al-Khawaldeh, Ahmed Saad Abdlkadir, Szeting Lee, Akram Al-Ibraheem
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe03/2024
Jahrgang / SeitenJg. 63 · S. 188-198
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Aim The integration of innovative radio-pharmaceutical agents targeting prostate-specific membrane antigen (PSMA) within nuclear medicine has transformed prostate cancer detection and management. This study aims to investigate the present landscape of [177Lu]Lu-PSMA in prostate cancer, elucidating trends, global contributions, scholarly outlets, institutions, and thematic concentrations with an aim to infor…
Zitieren
Zitierempfehlung
Rakan Al-Rashdan, Haneen Al-Abdallat, Mike Machaba Sathekge, Siroos Mirzaei, Mohammed Shahait, Khaled Al-Khawaldeh, Ahmed Saad Abdlkadir, Szeting Lee, Akram Al-Ibraheem (2024) Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses. Nuklearmedizin - NuclearMedicine, 63 (03), 188-198. https://doi.org/10.1055/a-2221-3036
Mit CareLit weiterarbeiten